Effect of the method to measure levels of glycated hemoglobin on individual clinical decisions: Comparison of an immunoassay with high-performance liquid chromatography

American Journal of Clinical Pathology

Volumn 132, Issue 3, 2009, Pages 332-335

  García Alcalá, Héctor ^a   Ruiz Argüelles, Alejandro ^a,b   Cedillo Carvallo, Beatriz ^b  

^a UPAEP University Hospital   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

Author keywords

Diagnostic evaluation; Glucose control; Hemoglobin A1c; Medical decision making

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL DECISION MAKING; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; BLOOD; BLOOD ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; IMMUNOASSAY; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 69849100135     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPIWRO1ST6HCIY     Document Type: Article

References (15)

1. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13(suppl 1):1-68.
2. American Diabetes Association. Standards of medical care in diabetes, 2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. John WG, Gray MR, Bates DL, et al. Enzyme immunoassay: a new method for estimating hemoglobin A1c. Clin Chem. 1993;39:663-666. (Pubitemid 23118319)
5. Grey V, Perlas M, Aebi C. Immunoturbidimetric method for determination of hemoglobin A1c. Clin Chem. 1996;42:2046-2047.
6. International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Scientific Division, Mosca A, Goodall I, Hoshino T, et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med. 2007;45:1077-1080.
7. 1c in human blood. Clin Chem Lab Med. 2002;40:78-89.
8. The DCCT Research Group. Feasibility of centralized measurements of glycated hemoglobin in the diabetes control and complications trial: a multicenter study. Clin Chem. 1987;33:2267-2271.
9. 1c: a 6-year progress report. Clin Chem. 2008;54:240-248.
10. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004;50:166-174.
11. 1c: a cause for concern? Am J Clin Pathol. 2008;129:540-547.
12. Marzullo C, Minery M. Evaluation of D10 hemoglobin testing system for hemoglobin A1c assay [in French]. Ann Biol Clin (Paris). 2008;66:95-99. (Pubitemid 351268792)
13. 1c measured by turbidimetric inhibition immunoassay. Am J Clin Pathol. 1998;109:274-278.
14. 1c on clinical chemistry analyzers. Clin Lab. 1999;45:123-137.
15. 1c determination. Diabetologia. 2004;47:1143-1148.